Skip to main content
logo
Noveris Health Sciences Inc. (CSE:NVRS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0750
0.00 (0.00%)
At close: Sep 18, 2026

Noveris Health Sciences Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.01
Revenue Growth
-----186.32%
Gross Profit
-----0.01
Operating Income
-0.91-0.51-2.51-9.39-15.84-22.33
Net Income
1.642.92-3.17-20.95-9.25-28.9
Earnings Per Share
0.092.37-2.66-34.12-53.48-308.62
EPS Growth
-46.97%-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.810.0100.046.961.5
Total Debt
0.379.586.875.424.784.5
Net Cash (Debt)
0.44-9.57-6.87-5.392.18-3.01
Net Cash Growth
------
Net Cash Per Share
0.02-7.75-5.76-8.7712.60-32.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.430.01-0.04-4.22-8.43-24.05
Capital Expenditures
------0.29
Free Cash Flow
-1.430.01-0.04-4.22-8.43-24.34
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----100.00%
Operating Margin
------298069.65%
Pretax Margin
------314732.56%
Profit Margin
------385658.60%
FCF Margin
------324889.79%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
0.880.13----
P/FCF Ratio
-40.84----
PS Ratio
-----4875.24